3-[3--4-(4-)]-5-[[()]]-2-ͪ Ӣ [3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl methanesulfonate ܶ 1.40.1 g/cm3 c 592.750.0 C at 760 mmHg ʽ C15H19FN2O6S 374.385 Wc 312.330.1 C | 374.094788
؛̖ | Ҏ(gu) | (sh) | r |
---|---|---|---|
Q-0106734 | 100mg |
1
|
ԃr |
Q-0106734 | 250mg |
1
|
ԃr |
Q-0106734 | 500mg |
1
|
ԃr |
Q-0106734 | 1g |
1
|
ԃr |
Q-0106734 | 5g |
1
|
ԃr |
3-[3--4-(4-)]-5-[[()]]-2-ͪ
Ӣ [3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl methanesulfonate
ܶ 1.4±0.1 g/cm3
c 592.7±50.0 °C at 760 mmHg
ʽ C15H19FN2O6S
374.385
Wc 312.3±30.1 °C
| 374.094788
PaƷ
(S)-2--3-((S)-2--3-)}} CAS:2628280-48-6
(R)-ʰ嶡}} CAS:256478-95-2
3,4--2-(()) CAS:2136287-65-3
N-(5,6-һ-2,3--1H--2-)-2,2,2- CAS:601487-87-0
N-̪-DL-Ȱ CAS:3343-28-0
4--3--2- CAS:170621-86-0
ʲ@ CAS:53956-04-1
B(ti)w/ĩ/Һ
aأ
rg1
棺
;
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|ָˣ | 95%+ |
ܽl | ЙC܄/ˮ |
CAS̖ | N/A |
N/A | |
l | -20ܹⱣ |
rg | 1 |
\ݔl | Ҝ2 |
aSң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ Danoprevir;ITMN-191; R7227; RO5190591; RG7227CAS850876-88-9 ^N/A N/A Hʹã
-
pgӹٷƼ˾ṩ DalfopristinCAS112362-50-2 ^N/A N/A Hʹ
-
3--4- Ӣ 3-Bromo-4-heptylbenzoic acid CAS̖ 81719-19-9 299.20300 ܶ N/A
-
3--4-(4-һh(hun)) Ӣ 3-Bromo-4-(4-ethylcyclohexyl)benzoic acid CAS̖ 1131622-57-5 311.21400 ܶ N/A